Researchers developed a 6-gene immune-related risk model to predict the survival of patients with lung adenocarcinoma (LUAD) in The Cancer Genome Atlas cohort based on TP53 status, and the predictive ability was confirmed in two independent cohorts.
[Journal of Cellular and Molecular Medicine]
6445212
SPXSDFJC
items
1
apa
0
default
asc
1
169896
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
